| Literature DB >> 31552195 |
Harry Pickering1, Christine D Palmer1, Joanna Houghton1, Pateh Makalo2, Hassan Joof2, Tamsyn Derrick1, Adriana Goncalves1, David C W Mabey1, Robin L Bailey1, Matthew J Burton1, Chrissy H Roberts1, Sarah E Burr1,2, Martin J Holland1,2.
Abstract
Background: Trachoma, a neglected tropical disease, is the leading infectious cause of blindness and visual impairment worldwide. Host responses to ocular chlamydial infection resulting in chronic inflammation and expansion of non-chlamydial bacteria are hypothesized risk factors for development of active trachoma and conjunctival scarring.Entities:
Keywords: conjunctival diseases; immune response; innate immunity; microbiome; trachoma
Mesh:
Substances:
Year: 2019 PMID: 31552195 PMCID: PMC6736612 DOI: 10.3389/fcimb.2019.00297
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Demographic characteristics of participants.
| 22 (61) | 30 (61) | 1.000 | 35 (29) | 38 (22) | 0.435 | |
| 6 (1–14) | 5 (1–13) | 0.275 | 53 (16–87) | 55 (16–84) | 0.119 | |
| 1.000 | 1.000 | |||||
| Dry season | 7 (19) | 9 (18) | 91 (75) | 118 (75) | ||
| Wet season | 29 (81) | 40 (82) | 30 (25) | 40 (25) | ||
| 0.445 | 0.938 | |||||
| Jola | 6 (17) | 6 (12) | 37 (31) | 48 (30) | ||
| Mandinka | 14 (39) | 17 (35) | 56 (46) | 76 (48) | ||
| Wolof | 11 (31) | 12 (24) | 10 (8) | 10 (6) | ||
| Other | 5 (14) | 14 (29) | 18 (15) | 24 (15) | ||
| 0.102 | 0.922 | |||||
| Basse | 0 (0) | 0 (0) | 15 (12) | 21 (9) | ||
| Brikama | 11 (31) | 15 (31) | 58 (48) | 79 (37) | ||
| Janjanbureh | 1 (3) | 0 (0) | 2 (2) | 4 (1) | ||
| Kanifing | 0 (0) | 0 (0) | 1 (1) | 1 (1) | ||
| Kerewan | 0 (0) | 3 (6) | 9 (7) | 12 (6) | ||
| Kuntaut | 3 (8) | 0 (0) | 7 (6) | 6 (4) | ||
| Mansa Konko | 21 (58) | 31 (63) | 19 (16) | 35 (22) | ||
| Unknown | 0 (0) | 0 (0) | 10 (8) | 0 (0) | ||
Figure 1Fold-changes in conjunctival gene expression between cases and matched, healthy controls. Magnitude of fold-changes in conjunctival gene expression between children with active trachoma and healthy controls (A) and adults with scarring trachoma and healthy controls (B), shown by bars. Colors highlight increased (red) or decreased (blue) expression in cases. P-values were considered significant at <0.05 and are denominated as follows: *p < 0.05; **p < 0.01; and ***p < 0.001.
Figure 2Comparison of fold-changes in conjunctival gene expression between active/scarring trachoma cases and healthy controls. Fold-changes in gene expression between children with active trachoma and healthy controls (orange bars) and adults with scarring trachoma and healthy controls (purple bars) are represented by bars with significance indicated as described below. Genes are sorted into three groups; downregulated in active and scarring trachoma (blue area), upregulated in active and scarring and trachoma (red area), and differentially regulated in active and scarring trachoma (green area). P-values were considered significant at <0.05 and are denominated as follows: *p < 0.05; **p < 0.01; and ***p < 0.001.
Figure 3Relative abundance of major phyla in children and adults by case-control status. Phyla with relative abundance >1% in either children or adults are shown. Phyla with relative abundance ≤1% are grouped into “Other.”
Figure 4Relative abundance of major genera in children and adults by case-control status. Genera with relative abundance >1% in either children or adults are shown. Genera with relative abundance ≤1% are grouped into “Other.”
Figure 5Ocular microbiome diversity in children and adults by case-control status. Hill number at corresponding order of diversity are shown for cases (red) and healthy controls (blue) in children (A) and adults (B). Boxes represent the interquartile range, with median indicated (blue line). Outer bars represent the range. P-values were considered significant at <0.05 and are denominated as follows: *p < 0.05; **p < 0.01; and ***p < 0.001.
Comparison of species-specific, ddPCR based test, and 16S genus-level operational taxonomic unit (OTU) classification.
| 16S negative (%) | 57 (76) | 26 (46) |
| 16S positive (%) | 18 (24) | 31 (54) |
| Sensitivity (%) | 76 | |
| Specificity (%) | 54 | |
| 16S negative (%) | 3 (3) | 0 (0) |
| 16S positive (%) | 97 (97) | 32 (100) |
| Sensitivity (%) | 100 | |
| Specificity (%) | 3 |
Associations between ocular microbiome and host genotype.
| C1/C1 | 0 (–) | – | 0 (–) | – | 0 (–) | – | 0 (–) | – |
| C1/C2 | 6.223 (3.784) | 0.103 | 7.846 (1.966) | 0.150 | −0.102 (0.114) | 0.373 | −0.063 (0.086) | 0.467 |
| C2/C2 | 0.663 (4.923) | 0.893 | −1.468 (2.559) | 0.567 | −0.111 (0.148) | 0.454 | 0.001 (0.112) | 0.994 |
| ≤ 1 copies | 0 (–) | – | 0 (–) | – | 0 (–) | – | 0 (–) | – |
| ≥2 copies | −5.848 (8.710) | 0.504 | −7.472 (4.742) | 0.119 | −0.468 (0.258) | 0.074 | −0.164 (0.198) | 0.412 |
| ≤ 1 copies | 0 (–) | – | 0 (–) | – | 0 (–) | – | 0 (–) | – |
| ≥2 copies | −5.798 (4.367) | 0.188 | −4.311 (2.377) | 0.073 | −0.128 (0.132) | 0.335 | −0.045 (0.104) | 0.663 |
| wt/wt | 0 (–) | – | 0 (–) | – | 0 (–) | – | 0 (–) | – |
| wt/del | −2.331 (3.836) | 0.545 | −1.736 (2.005) | 0.388 | −0.180 (0.113) | 0.115 | 0.056 (0.085) | 0.510 |
| del/del | 3.644 (5.188) | 0.484 | 0.816 (2.712) | 0.764 | −0.030 (0.153) | 0.846 | 0.182 (0.115) | 0.115 |
Significant associations between host gene expression and ocular microbes in children.
| S100A7 | 1.5 × 10−5 | 7.15 (1.52) | |
| SRGN | 3.4 × 10−5 | 3.04 (0.68) | |
| TLR4 | 6.2 × 10−5 | 2.43 (0.57) | |
| miR-155 | 0.00016 | −6.10 (1.51) |
Figure 6Plot of the ocular microbiome, modular conjunctival gene expression, and trachomatous disease in children. Non-metric multidimensional scaling of the complete ocular microbial community was used to position samples (points), enrichment of genera with relative abundance >1% are shown (black text). Arrows represent conjunctival gene expression modules (purple text), arrow coordinates indicate increased expression in surrounding samples. Shaded areas highlight the distribution of active trachoma (red) and healthy control (blue) samples.
Significant associations between host gene expression and ocular microbes in adults.
| CEACAM1 | 0.0009 | 1.37 (0.39) | |
| MUC1 | 0.0001 | 1.25 (0.32) | |
| MUC4 | 0.0003 | 1.48 (0.39) |
Figure 7Plot of the ocular microbiome, modular conjunctival gene expression, and trachomatous disease in adults. Non-metric multidimensional scaling of the complete ocular microbial community was used to position samples (points), enrichment of genera with relative abundance >1% are shown (black text). Arrows represent conjunctival gene expression modules (purple text), arrow coordinates indicate increased expression in surrounding samples. Shaded areas highlight the distribution of scarring trachoma (red) and healthy control (blue) samples.